News
ALC
63.78
+2.84%
1.76
Alcon price target lowered to CHF 70 from CHF 77 at Deutsche Bank
TipRanks · 20h ago
Weekly Report: what happened at ALC last week (0504-0508)?
Weekly Report · 2d ago
Alcon Earnings Call Highlights Growth Amid Margin Strains
TipRanks · 2d ago
Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?
Benzinga · 3d ago
Alcon Price Target Cut to $78.00/Share From $90.00 by Barclays
Dow Jones · 4d ago
Alcon Is Maintained at Equal-Weight by Barclays
Dow Jones · 4d ago
Barclays Maintains Equal-Weight on Alcon, Lowers Price Target to $78
Benzinga · 4d ago
LENSAR Q1 revenue falls 5%, hurt by merger uncertainty; recurring revenue rises 9%
Reuters · 5d ago
LENSAR Q1 FY26 swings to net income of $36.3 million; revenue falls 5% to $13.4 million
PUBT · 5d ago
Alcon price target lowered to $78 from $90 at Barclays
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Argenx Se (ARGX) and Definium Therapeutics (DFTX)
TipRanks · 5d ago
Alcon price target lowered to $90 from $98 at Baird
TipRanks · 5d ago
Alcon price target lowered to $85 from $95 at Mizuho
TipRanks · 5d ago
Alcon Is Maintained at Overweight by Wells Fargo
Dow Jones · 5d ago
Alcon Price Target Cut to $86.00/Share From $97.00 by Wells Fargo
Dow Jones · 5d ago
Wells Fargo Maintains Overweight on Alcon, Lowers Price Target to $86
Benzinga · 5d ago
Alcon Is Maintained at Outperform by Mizuho
Dow Jones · 6d ago
Alcon Price Target Cut to $85.00/Share From $95.00 by Mizuho
Dow Jones · 6d ago
Mizuho Maintains Outperform on Alcon, Lowers Price Target to $85
Benzinga · 6d ago
Alcon forecasts 5%-7% sales growth and announces $1.5B share repurchase program amid reduced tariff assumption
Seeking Alpha · 6d ago
More
Webull provides a variety of real-time ALC stock news. You can receive the latest news about Alcon Inc through multiple platforms. This information may help you make smarter investment decisions.
About ALC
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.